Viral Infections and Antiviral Therapies 2023
DOI: 10.1016/b978-0-323-91814-5.00018-0
|View full text |Cite
|
Sign up to set email alerts
|

Strategies for delivery of antiviral agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 350 publications
0
1
0
Order By: Relevance
“…The development of new efficient antiviral drugs was significant. Although the number of newly developed antiviral active chemicals has increased with advances in chemical synthesis technologies, mostly synthetic antiviral drugs were insoluble in water, such as ritonavir, lopinavir, tipranavir, acyclovir, atazanavir, amprenavir [ 1 ]. For example, amprenavir, a non-peptide protease inhibitor of taurine, has a aqueous solubility of only 0.04 mg/mL.…”
Section: Introductionmentioning
confidence: 99%
“…The development of new efficient antiviral drugs was significant. Although the number of newly developed antiviral active chemicals has increased with advances in chemical synthesis technologies, mostly synthetic antiviral drugs were insoluble in water, such as ritonavir, lopinavir, tipranavir, acyclovir, atazanavir, amprenavir [ 1 ]. For example, amprenavir, a non-peptide protease inhibitor of taurine, has a aqueous solubility of only 0.04 mg/mL.…”
Section: Introductionmentioning
confidence: 99%